Selective cdk 4/6 inhibitor cancer therapeutics
US-2024116942-A1 · Apr 11, 2024 · US
Spiro-condensed systems
Spiro-condensed systems · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D487/20 |
| Official title | Spiro-condensed systems |
| Display label | Spiro-condensed systems |
| Total patents | 175 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 21 |
| 2016 | 20 |
| 2017 | 16 |
| 2018 | 17 |
| 2019 | 16 |
| 2020 | 14 |
| 2021 | 16 |
| 2022 | 13 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 9 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
US-10138251-B2 · Nov 27, 2018 · US
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
US-10077243-B2 · Sep 18, 2018 · US
Process for making CGRP receptor antagonists
US-9850246-B2 · Dec 26, 2017 · US
Tricyclic lactams for use in hspc-sparing treatments for rb-positive abnormal cellular proliferation
US-2017333440-A1 · Nov 23, 2017 · US
Spirocyclic Heterocyclic Compounds Useful As HIV Integrase Inhibitors
US-2017334924-A1 · Nov 23, 2017 · US
Substituted polycyclic carbamolypyridone derivative
US-9815835-B2 · Nov 14, 2017 · US
Chemical compounds
US-9814699-B2 · Nov 14, 2017 · US
Spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
US-2017247394-A1 · Aug 31, 2017 · US
Lactam kinase inhibitors
US-9745316-B2 · Aug 29, 2017 · US
Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal cellular proliferation
US-9717735-B2 · Aug 1, 2017 · US
Organic Electroluminescent Materials and Devices
US-2017186977-A1 · Jun 29, 2017 · US
SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS
US-2017174690-A1 · Jun 22, 2017 · US
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
US-2017119774-A1 · May 4, 2017 · US
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
US-9598423-B2 · Mar 21, 2017 · US
Fused heterocyclic compounds as protein kinase inhibitors
US-2017073349-A1 · Mar 16, 2017 · US
CDK Inhibitors
US-2017057971-A1 · Mar 2, 2017 · US
Lactam kinase inhibitors
US-2017057972-A1 · Mar 2, 2017 · US
Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators
US-9556188-B2 · Jan 31, 2017 · US
Substituted polycyclic carbamolypyridone derivative
US-2016368921-A1 · Dec 22, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D487/20?
- CPC C07D487/20 is the Cooperative Patent Classification code for “Spiro-condensed systems.”
- How many patents are filed under CPC C07D487/20 (Spiro-condensed systems)?
- Our database includes 175 publications tagged with this CPC code.
- Is patent activity under CPC C07D487/20 growing?
- Publication counts under this code: 15 in 2024 vs 9 in 2025 (latest complete years).